Jacqueline Jonklaas MD
Adrenal Disease, Diabetes, Pituitary Disorders & Neuroendocrinology, Thyroid
Professor, Medicine, Georgetown University School of Medicine
Join to View Full Profile
4000 Reservoir Rd NwBldg D Suite 230Washington, DC 20007
Phone+1 202-687-2818
Dr. Jonklaas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
MedStar Health/Georgetown University HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1996 - 1998- MedStar Health Georgetown University/Georgetown HospitalResidency, Internal Medicine, 1993 - 1996
Georgetown University School of MedicineClass of 1993
Certifications & Licensure
DC State Medical License 1997 - 2027
MD State Medical License 2000 - 2002
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy Start of enrollment: 2004 Dec 01
- The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma Start of enrollment: 2012 Sep 01
Publications & Presentations
PubMed
- Patient and Provider Perspectives of a Web-Based Intervention to Support Symptom Management After Radioactive Iodine Treatment for Differentiated Thyroid Cancer: Quali...Alaina L Carr, Angela M Jenkins, Jacqueline Jonklaas, Kate Gabriel, Kristen E Miller
JMIR Formative Research. 2025-03-19 - Patient and Provider Perspectives of a Web-based Intervention to Support Symptom Management after Radioactive Iodine Treatment for Differentiated Thyroid Cancer: Quali...Alaina L Carr, Angela Marie Jenkins, Jacqueline Jonklaas, Kate Gabriel, Kristen Miller
JMIR Formative Research. 2025-02-12 - Radioactive Iodine Treatment for Thyroid Cancer Complicated by Lacrimal Sac Retention of Iodine.Annu Suresh, Giuseppe Esposito, Bruce Davidson, Pavle Doroslovački, Jacqueline Jonklaas
JCEM Case Reports. 2025-01-01
Lectures
- Thyroid Hormone Preparations: If, When, and Why You Should Deviate from LevothyroxineENDO 2019 - New Orleans, LA - 3/23/2019
- ESAP LiveENDO 2019 - New Orleans, LA - 3/24/2019
- Thyroid Hormone Preparations: If, When, and Why You Should Deviate from Levothyroxine (Repeat)ENDO 2019 - New Orleans, LA - 3/23/2019
- Join now to see all
Authored Content
- What Does the Future Hold for T3 and T4 Combination Therapy Studies?November 2019
Press Mentions
AACE 2025: Innovation, Education and Impact – A Letter from Dr. Scott IsaacsApril 25th, 2025- Examining T4/T3 Combination Therapy in HypothyroidismNovember 21st, 2024
- Preview of the 93rd American Thyroid Association Annual MeetingJuly 1st, 2024
- Join now to see all
Grant Support
- Use of a decision aid to resolve uncertainty about radioactive iodine treatment in patients with intermediate-risk thyroid cancer: the Radiance trialGEORGETOWN UNIVERSITY2022–2030
- Serum Selenium Levels And Thyroid Cancer DevelopmentNational Center For Research Resources2008–2009
- Identification Of Leukocyte Genes That Are Regulated By Thyroid HormoneNational Center For Research Resources2008
- Comparison Of Thyroid Hormone Levels Found With Normal Thyroid Functioning, CNational Center For Research Resources2008
- Comparison Of Cortison Levels During An ACTH Stimulation Test Using Tandem MassNational Center For Research Resources2007
- Identification Of Leukocyte Genes That Are Regulated By Thyroid HormoneNational Center For Research Resources2006–2007
- Comparison Of Thyroid Hormone Levels Found With Normal Thyroid Functioning, CNational Center For Research Resources2006–2007
- Mentored Patient-Oriented Research Career Development AwardNational Center For Research Resources2005–2006
- Levothyroxine: Triiodothyronine Combination Therapy For HypothyroidismNational Center For Research Resources2005
- Thyroid Hormone Levels With Normal Thyroid To Level After ThyroidectomyNational Center For Research Resources2004
- Levothyroxine: Triiodothyronine Combination TherapyNational Center For Research Resources2002–2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
